Ascent Group, LLC Novartis Ag Transaction History

Ascent Group, LLC

$1.29 Billion
Q4 2024

A detailed history of Ascent Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Ascent Group, LLC holds 6,848 shares of NVS stock, worth $766,154. This represents 0.05% of its overall portfolio holdings.

Number of Shares

6,848

Previous 6,691 2.35%

Holding current value

$766,154

Previous $769,000 13.39%

% of portfolio

0.05%

Previous 0.06%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 21, 2025	BUY	$96.78 - $117.18 $15,194 - $18,397	157 Added 2.35%	6,848 $666,000
Q3 2024 Nov 14, 2024	BUY	$106.13 - $120.89 $29,185 - $33,244	275 Added 4.29%	6,691 $769,000
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $31,936 - $37,042	345 Added 5.68%	6,416 $683,000
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $18,006 - $20,500	-189 Reduced 3.02%	6,071 $587,000
Q4 2023 Feb 13, 2024	SELL	$92.27 - $101.54 $26,666 - $29,345	-289 Reduced 4.41%	6,260 $632,000
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $55,132 - $61,185	-582 Reduced 8.16%	6,549 $667,000
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $9,066 - $10,281	-98 Reduced 1.36%	7,131 $719,000
Q1 2023 May 10, 2023	SELL	$80.03 - $92.81 $2,320 - $2,691	-29 Reduced 0.4%	7,229 $665,000
Q4 2022 Feb 16, 2023	BUY	$75.55 - $92.52 $3,626 - $4,440	48 Added 0.67%	7,258 $658,000
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $44,542 - $52,094	597 Added 9.03%	7,210 $585,000
Q2 2022 Aug 05, 2022	BUY	$80.52 - $93.75 $32,771 - $38,156	407 Added 6.56%	6,613 $568,000
Q1 2022 May 10, 2022	BUY	$80.11 - $90.62 $240,249 - $271,769	2,999 Added 93.51%	6,206 $545,000
Q4 2021 Mar 01, 2022	BUY	$79.7 - $88.13 $255,597 - $282,632	3,207 New	3,207 $279,000

Others Institutions Holding NVS

# of Institutions

1,477

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $241B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Group, LLC with notifications on news.

Account